Recombinant Yersinia pseudotuberculosis serotype O:3 Urocanate hydratase (hutU), partial

What is Yersinia pseudotuberculosis serotype O:3 and its significance in research?

Yersinia pseudotuberculosis is a zoonotic pathogenic bacterial species belonging to the family Enterobacteriaceae. It causes yersiniosis, an acute intestinal infection in humans and animals. The serotype O:3 is particularly significant as it shares substantial genetic similarity with Y. enterocolitica O:3, making it valuable for comparative studies of pathogenicity mechanisms. Y. pseudotuberculosis is frequently implicated in lethal epidemics among zoo animals and can cause significant reductions in breeding populations, with limited prevention methods currently established . Research on this organism is critical for understanding bacterial pathogenesis and developing preventive strategies such as vaccines against yersiniosis.

What is Urocanate hydratase (hutU) and what role does it play in Y. pseudotuberculosis?

Urocanate hydratase (hutU) is an enzyme involved in histidine metabolism that catalyzes the conversion of urocanate to 4-imidazolone-5-propionate. In Y. pseudotuberculosis, hutU is part of the histidine utilization (hut) pathway, which allows the bacterium to use histidine as a carbon and nitrogen source. While specific research on hutU in Y. pseudotuberculosis serotype O:3 is limited in the provided search results, studies of similar metabolic enzymes in related Yersinia species suggest that hutU may play roles in bacterial adaptation to different host environments and nutrient availability conditions during infection.

How does one verify the expression and functionality of recombinant hutU from Y. pseudotuberculosis?

Verification of recombinant hutU expression and functionality involves multiple methodological approaches:

• Protein expression verification: Western blot analysis using anti-hutU antibodies or antibodies against fusion tags (similar to methods used for YopE and LcrV detection)

• Size verification: SDS-PAGE alongside prestained protein markers to confirm the correct molecular weight of the recombinant protein

• Enzymatic activity assay: Spectrophotometric measurement of urocanate conversion to 4-imidazolone-5-propionate

• Structural integrity assessment: Circular dichroism to verify proper protein folding

For example, when verifying other recombinant Yersinia proteins, researchers have successfully used Western blot analysis to confirm both protein synthesis and secretion patterns under different growth conditions, as demonstrated with YopE and LcrV proteins .

What expression systems are most efficient for producing recombinant Y. pseudotuberculosis hutU?

The optimal expression system for recombinant hutU from Y. pseudotuberculosis serotype O:3 depends on research objectives and downstream applications. Based on methodologies used for other Yersinia proteins:

Research on YopE fusion proteins has demonstrated successful expression using genetically engineered E. coli systems , suggesting similar approaches may be effective for hutU production.

How should researchers design deletion mutants to study hutU function in Y. pseudotuberculosis?

When designing deletion mutants to study hutU function:

• Target specific regions: Design primers that flank the hutU gene in the Y. pseudotuberculosis genome

• Marker selection: Choose appropriate antibiotic resistance markers (e.g., kanamycin resistance as used in YeO3-hfq::Km mutants)

• Complementation strategy: Develop plasmid constructs containing the wild-type hutU gene for complementation studies to confirm phenotype specificity

• Verification approach: Implement PCR verification, sequencing, and expression analysis via RT-PCR or RNA-seq to validate the deletion

The methodological approach used for creating ΔyopK ΔyopJ Δasd triple mutations provides a useful template for targeting multiple genetic elements in Yersinia, which could be adapted for hutU studies.

What are the key considerations when purifying recombinant hutU for functional studies?

Purification of recombinant hutU requires careful attention to several factors:

• Buffer optimization: Determine optimal pH and salt concentrations for maintaining hutU stability and activity

• Purification strategy: Implement multi-step purification using affinity chromatography (e.g., His-tag), followed by ion exchange and size exclusion chromatography

• Activity preservation: Add stabilizing agents or cofactors required for hutU function

• Quality control: Verify purity by SDS-PAGE and functional integrity through enzyme activity assays

• Storage conditions: Establish optimal storage conditions (temperature, buffer composition) to maintain long-term stability

For insoluble recombinant proteins like those described in Y. pseudotuberculosis research , additional refolding protocols may be necessary to obtain functionally active protein.

How can transcriptomic and proteomic approaches be integrated to study hutU regulation in Y. pseudotuberculosis?

Integration of transcriptomic and proteomic methodologies provides comprehensive insights into hutU regulation:

• RNA-seq analysis: Quantify hutU transcript levels under various environmental conditions or in different genetic backgrounds

• Quantitative proteomics (LC-MS/MS): Measure hutU protein abundance and identify post-translational modifications

• Integration strategies:

  • Correlation analysis between mRNA and protein levels

  • Pathway enrichment analysis to identify regulatory networks

  • Network modeling to predict regulatory interactions

This approach has been successfully applied to study Hfq-dependent alterations in Y. enterocolitica O:3, revealing profound changes in gene and protein expression profiles . Similar methodologies could be applied to investigate hutU regulation, particularly in response to nutrient availability or host-related signals.

What is the role of hutU in Y. pseudotuberculosis virulence and host interaction?

While the specific role of hutU in virulence is not directly addressed in the provided search results, research methodologies can be adapted from related studies:

• Infection models: Compare the virulence of wild-type and hutU-deficient Y. pseudotuberculosis in mouse models, measuring survival rates and bacterial burden in tissues

• Cellular assays: Assess bacterial adhesion, invasion, and survival within host cells

• Metabolic profiling: Determine whether hutU activity affects bacterial metabolism during infection

• Host response analysis: Evaluate host immune responses to wild-type versus hutU mutant strains

Studies on other Y. pseudotuberculosis virulence factors have demonstrated that recombinant proteins can induce protective immunity, as observed with YadA, which achieved 100% survival rate in immunized mice compared to 0% in control groups .

How does the structure and function of hutU compare between Y. pseudotuberculosis and related pathogenic species?

Comparative analysis of hutU across bacterial species provides evolutionary and functional insights:

• Sequence alignment: Compare hutU sequences from Y. pseudotuberculosis, Y. enterocolitica, Y. pestis, and other bacterial species to identify conserved domains and species-specific variations

• Structural modeling: Use homology modeling and structural prediction tools to compare three-dimensional conformations

• Functional comparison: Assess enzymatic parameters (Km, Vmax, substrate specificity) across species

• Phylogenetic analysis: Construct evolutionary trees to understand the relationship between hutU variants

The comparative genomics approach used to study Y. pestis and Y. pseudotuberculosis at Institut Pasteur exemplifies how such methodologies can reveal insights into functional conservation and specialization of metabolic enzymes across species.

What are common challenges in expressing and purifying active recombinant hutU, and how can they be addressed?

Researchers often encounter several challenges when working with recombinant hutU:

When working with insoluble recombinant proteins from Yersinia species, researchers have successfully used specialized approaches, as demonstrated in the study of rYadA produced in genetically engineered E. coli .

How can researchers design experiments to study the interaction between hutU and host cell components?

To investigate potential interactions between hutU and host cell components:

• Pull-down assays: Use tagged recombinant hutU to identify host proteins that interact with the bacterial enzyme

• Yeast two-hybrid screening: Screen for host protein interactions with hutU

• Immunofluorescence microscopy: Visualize the localization of hutU during host cell infection

• FRET analysis: Measure direct protein-protein interactions in real-time

• Mass spectrometry: Identify host proteins that co-purify with hutU during infection

Research approaches used to study Yersinia-host interactions at the cellular level at Institut Pasteur provide methodological frameworks that could be adapted for investigating hutU-specific interactions.

What advanced analytical techniques are recommended for studying the catalytic mechanism of hutU?

Advanced analytical techniques for investigating hutU catalytic mechanisms include:

• Enzyme kinetics analysis: Determine Km, Vmax, and substrate specificity under various conditions

• Site-directed mutagenesis: Systematically modify putative catalytic residues to determine their functional roles

• X-ray crystallography or cryo-EM: Determine the three-dimensional structure of hutU, alone and in complex with substrates or inhibitors

• NMR spectroscopy: Analyze protein dynamics and substrate binding

• QM/MM simulations: Model the reaction mechanism and energy landscape

These approaches can provide detailed insights into how hutU functions at the molecular level, potentially revealing unique features that distinguish the Y. pseudotuberculosis enzyme from homologs in other species.

How might hutU be utilized in developing new diagnostic tools for Y. pseudotuberculosis infections?

Development of hutU-based diagnostic approaches could include:

• Recombinant hutU as an antigen: Generate specific antibodies for immunoassay development

• PCR-based detection: Design primers targeting the hutU gene for molecular diagnosis

• Metabolic profiling: Detect specific metabolites produced by hutU activity as biomarkers of infection

• CRISPR-Cas diagnostic systems: Target hutU sequences for rapid, specific detection

The molecular epidemiology typing tools being developed at the Yersinia Research Unit could incorporate hutU-specific markers to improve identification and characterization of Y. pseudotuberculosis strains.

What is the potential of recombinant hutU in vaccine development against Y. pseudotuberculosis?

While hutU itself has not been specifically studied as a vaccine candidate in the provided search results, insights from other recombinant Yersinia proteins suggest potential approaches:

• Antigenicity assessment: Evaluate the immunogenicity of recombinant hutU in animal models

• Adjuvant formulation: Test various adjuvant combinations to enhance immune responses

• Delivery systems: Explore different delivery methods, including oral administration (as demonstrated with other Y. pseudotuberculosis antigens)

• Protection studies: Conduct challenge experiments to assess protective efficacy

Research on recombinant YadA demonstrated 100% survival rates in immunized mice compared to 0% in control groups , suggesting that properly identified and formulated recombinant proteins from Y. pseudotuberculosis can induce protective immunity.

How can systems biology approaches enhance our understanding of hutU's role in Y. pseudotuberculosis metabolism and pathogenesis?

Systems biology methodologies offer comprehensive insights into hutU function:

• Metabolic modeling: Develop genome-scale metabolic models to predict the impact of hutU on bacterial metabolism

• Network analysis: Map the regulatory and metabolic networks associated with hutU activity

• Multi-omics integration: Combine transcriptomics, proteomics, and metabolomics data to understand system-wide effects of hutU modulation

• Host-pathogen interaction modeling: Simulate the impact of hutU on host-pathogen dynamics

The comparative genomics and transcriptomics approaches employed by the Yersinia Research Unit demonstrate how these methodologies can reveal the complex interplay between bacterial metabolism and pathogenicity.